To report an adverse event involving a ScieGen product,
please contact our Drug Safety team:
Drug Safety
- 1-855-724-3436
- drugsafety@sciegenpharm.com
- www.fda.gov/medwatch
- FDA at 1-800-FDA-1088
If this is an emergency, please contact your doctor, pharmacist, or dial 911.
US Formulation Unit 1
ScieGen Pharmaceuticals
89 Arkay Drive, Hauppauge,
New York 11788.
- (631) 434-2723
US Formulation Unit 2 & Corporate HQ
ScieGen Pharmaceuticals
330 Oser Avenue, Hauppauge,
New York 11788.
New York 11788.
- (631) 524-5517
India Formulation Unit 1
ScieGen Pharmaceuticals Pvt Ltd
Sy.No. 408 to 412, 418 to 434, Plot No. 10-14; TSIIC, GIP, Polepally Village, Jadcherla Mandal, Mahabubnagar, Telangana-509 301.
India Corporate Office
ScieGen Pharmaceuticals Pvt. Ltd.
4th Floor, Survey of India, Azura Heights, Road No: 35, Plot No: 238, 100 Feet Rd, Ayyappa Society, Madhapur, Hyderabad, Telangana 500081, India
Sales Inquiries
For any sales or product inquiries, please contact:
General Inquiries
For any general inquiries, please contact:
Human Resources
For any HR related inquiries, please contact:
Customer Service
For any Customer Service inquiries, please contact:
Building 2
ScieGen Pharmaceuticals
330 Oser Avenue, Hauppauge,
New York 11788.
New York 11788.
- (631) 524-5517
- info@sciegenpharm.com
R&D Centre - India
ScieGen Pharmaceuticals Pvt. Ltd.
Plot No.70 & 71, Ground Floor,
ALEAP Industrial Area, Pragathi Nagar,
Hyderabad – 500 090. Telangana. India.
- +91 - 70365 00011
- info@sciegenpharm.com
